Showing 1 - 5 results of 5 for search 'Emiliano Calvo', query time: 0.02s Refine Results
  1. 1
    Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial

    Nemvaleukin alfa monotherapy in patients with advanced melanoma and renal cell carcinoma: results from the phase 1/2 non-randomized ARTISTRY-1 trial by Xiaomin He, Emiliano Calvo, David F McDermott, Valentina Boni, Olivier Dumas, Arvind Chaudhry, Sang Joon Shin, Seth D Rosen, Philip R Debruyne, Ulka N Vaishampayan

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations

    In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations by Cristina Nieto-Jiménez, Esther Garcia-Lorenzo, Cristina Diaz-Tejeiro, Lucía Paniagua-Herranz, Adrián Sanvicente, Bernard Doger, Irene Moreno, Manuel Pedregal, Jorge Bartolomé, Arancha Manzano, Gyöngyi Munkácsy, Balázs Győrffy, Pedro Pérez-Segura, Emiliano Calvo, Victor Moreno, Alberto Ocana

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Mapping MAGE-A4 expression in solid cancers for targeted therapies

    Mapping MAGE-A4 expression in solid cancers for targeted therapies by Christin Habigt, Sylvie Rottey, Iben Spanggaard, Juanita S. Lopez, Elena Garralda, Emiliano Calvo, Oliver Bechter, Oliver Bechter, Jayesh Desai, Rachel Galot, Leena Gandhi, Florian Heil, Natascha Rieder, Ivan Dimitrov, Iris Martinez Quetglas, Christian Heichinger, Nino Keshelava, Andreas Roller

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1)

    Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1) by Lucy Gilbert, Jameel Muzaffar, Vamsidhar Velcheti, Anna Spreafico, Emiliano Calvo, David F McDermott, Marc S Ernstoff, Valentina Boni, Karl D Lewis, Ira Winer, Olivier Dumas, Aman Chauhan, Arvind Chaudhry, Christoper J Hoimes, Seth D Rosen, Debora S Bruno, James F Strauss, Rita Dalal, Ulka N Vaishampayan, Quincy S Chu

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors

    Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors by Jeanne Tie, Dirk Jäger, Victor Moreno, Dirk Nagorsen, Gloria Juan, Kyriakos P Papadopoulos, Anthony J Olszanski, Erik Rasmussen, Nehal Lakhani, Albiruni RA Razak, James M Cleary, Michael Boyer, Emiliano Calvo Aller, William Edenfield, R Donald Harvey, Annemie Rutten, Manish A Shah, David P Ryan, Hansen Wong, Neelesh Soman, Marie-Anne Damiette Smit

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: